ABSTRACT
INTRODUCTION
Poxviruses are double-stranded DNA with cytoplasmic multiplication. They have a number of autonomous elements allowing this intracytoplasmic multiplication unlike the majority of other viruses [1] . Several genes of this family of viruses including Orthopoxviruses (OPV) and Molluscum contgiosum virus (MCV) are involved in skin infections in humans and other vertebrates.
Since the 1980s, the smallpox virus belonging to the Orthopox virus group has been eradicated [2] . However, viruses such as Monkeypox virus, Cowpox virus and other OPVs continue to infect humans accidentally but with a less severe degree of virulence than the smallpox virus [3] . Their eradication is problematic because they have many reservoirs. The emergence of Monkeypox virus, especially in Central Africa, with the epidemiological characteristics of the epidemic of 1996 -1997 in Zaire [3] and the appearance of the virus in 2003 in the USA makes it a global concern. Clinically, confusion has already been made between certain oxic infections and chickenpox according to the literature [5, 6] . Côte d'Ivoire is a probable zone of virus circulation [7, 8] . Despite this fact, diagnostic methods for OPVs in general and Monkeypox virus in particular are non-existent.
The MCV is increasingly encountered with HIV infection. It is often involved in skin lesions in children. To date, in Côte d'Ivoire, the diagnosis of this virus remains essentially clinical whereas atypical clinical forms were encountered with HIV infection [9, 10] .
In order to monitor the emergence of this group of viruses in the population in Côte d'Ivoire, it could be necessary to set up molecular diagnostic tools to detect a certain number of viruses of this family.
MATERIALS AND METHODS:
This is an experimental study of the analytical type carried out at the Pasteur Institute of Côte d'Ivoire on the site of Adiopodoumé to the platform of molecular biology in 2016.
Biological material
In this study, the following biological products were used: strains of Cowpox virus derived from Cowpox virus culture on a Vero cell supplied by the Pasteur Institute of Bangui for the technical development of the detection of the Orthopoxviruses. Cutaneous lesions of 21 patients suspected of MCV infection for the detection of the Molluscum contagiosum virus. Microorganisms involved in cutaneous infections in Côte d'Ivoire from various biological products of patients were used for primer specificity tests (Table 1) . 
METHODS
Pre-treatment of samples The cutaneous lesions were ground with mortar and dissolved in 2 ml of 1X PBS. They were then stored at -20 ° C until extraction of the DNA.
DNA extraction
The DNAs of the different microorganisms were extracted using the Nuclisens magnetic extraction protocol (Biomerieux). Briefly 400 µl samples were added to 800 µl of lysis buffer and incubated for 10 min. Then 40 µl of magnetic silica was added to the mix and incubated for 10 minutes at laboratory temperature. The solution was centrifuged for 30 s at 13000 rpm. A series of washing was carried out on the silica-DNA complex using the Minimag (Biomerieux). An elution buffer was used after washing to collect 25 µl of DNA.
Amplification
and revelation A PCR using consensus primers of Orthopoxviruses designed from the virus surface membrane HA gene were used (Forward: EACP1: 5 'ATG ACA CGA TTG CCA ATA C 3', Reverse: EACP2: 5 'CTA GAC TTT GTT TTC TG 3 '; the desired PCR product band size being 942 bp [11] . Amplification conditions were as followingfor the detection of The GoTaq G2 Flexi DNA polymerase kit (Promega Corporation, USA) was used for the PCR mixes containing 0.2µM of each primer, 1.5µM, MgCl, 0.1µM dNTPs, 1 unit Taq polymerase, 1X of buffer and 5µl of DNA template for a final volume of 50µl. The revelation was made on a GelDoc Bioanalyzer (BioRad) after electrophoresis on 1.5% agarose gel.
Study
of sensitivity It was made from a dilution series from the DNA extracted of the Cowpoxvirus viral strain for Orthopoviruses and a positive DNA MCV sample.
of the specificity It was realized by carrying out PCR from the primers specific to OPV (EACP1, EACP2) and MCV (MCV1, MCV2) in the presence of DNA from different microorganisms mentioned in Table 1 .
RESULTS
The PCR carried out using our positive Cowpox virus DNA control allowed us to validate our method of amplification. Indeed, two samples corresponding to the pure sample and the dilutions 10 -1 of our controls were positive (FIG. 1) The MCV detection tests were performed using cutaneous lesions from 21 patients diagnosed with MCV infection clinically. The patients had the epidemiological and clinical characteristics presented in Table 2 . (Figure 3 ). The 167 bp PCR product was revealed for all three samples corresponding to positive MCV detection results.
FIGURE 3: MCV PCR TEST OF SAMPLES
A dilution series of 10 -1 to 10 -9 was carried out with the 1 / YOP sample in order to determine the sensitivity threshold of the PCR. Positive bands were observed up to 10-6 dilution ( Figure 4 17, 18] , hence the need for a biological diagnosis despite the strong clinical suspicion.
CONCLUSION

The emergence of Monkeypox virus in Central
Africa is a signal for West Africa. It is necessary to set up rapid diagnostic methods. This study is part of this approach. However, its sensitivity needs to be improved. Real-time PCR implementation is also a solution.
